EARNINGS CALL ARCHIVE 1 CALL ON FILE

XENE — Xenon Pharmaceuticals Inc.

NASDAQ

Q3 2025 Earnings Call Summary

NOV 4, 2025

REVENUE

EPS

-$1.15 -7.5%

FREE CASH FLOW

-$72.0M -11.9%

No summary has been written for this call yet.